Capital Investment Advisory Services’s Verrica Pharmaceuticals VRCA Stock Holding History

Capital Investment Advisory Services’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,513	Closed	-$189K	–	836
2021 Q3	$189K	Hold	1,513	–	–	0.02%	455
2021 Q2	$171K	Hold	1,513	–	–	0.02%	476
2021 Q1	$229K	Hold	1,513	–	–	0.03%	386
2020 Q4	$174K	Buy	+1,513	New	+$139K	0.03%	428
2020 Q3	–	Sell	-1,563	Closed	-$172K	–	661
2020 Q2	$172K	Hold	1,563	–	–	0.03%	326
2020 Q1	$171K	Buy	1,563 +150	+11%	+$19.7K	0.04%	299
2019 Q4	$224K	Buy	1,413 +173	+14%	+$25.5K	0.06%	280
2019 Q3	$183K	Hold	1,240	–	–	0.05%	284
2019 Q2	$125K	Hold	1,240	–	–	0.04%	350
2019 Q1	$134K	Hold	1,240	–	–	0.05%	280
2018 Q4	$101K	Buy	1,240 +170	+16%	+$20.6K	0.04%	295
2018 Q3	$174K	Hold	1,070	–	–	0.08%	215
2018 Q2	$211K	Buy	+1,070	New	+$210K	0.11%	189

Other funds holding VRCA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Investment Advisory Services's VRCA Position: Q4 2021 in Review

Capital Investment Advisory Services sold out of Verrica Pharmaceuticals (VRCA) in Q4 2021, closing a stake of 1,513 shares — an estimated $189K sold.

Capital Investment Advisory Services first reported a position in VRCA in Q2 2018 and held it in 13 quarters. The position peaked at $229K in Q1 2021. 45 funds tracked by Wall St. Rank hold VRCA as of Q4 2021.

Capital Investment Advisory Services reported no remaining Verrica Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Capital Investment Advisory Services sold 1,513 Verrica Pharmaceuticals shares in Q4 2021, an estimated $189K.
Capital Investment Advisory Services first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 13 quarters.
Capital Investment Advisory Services's Verrica Pharmaceuticals position peaked at $229K in Q1 2021.
45 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2021.

Based on Capital Investment Advisory Services's 13F filing for Q4 2021, filed 1 Feb 2022.